Mipet Meloxaid (NF) Oral Susp Dog 100ml
Meloxaid 1.5 mg/ml Oral Suspension for Dogs
Alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders in dogs.
Shake well before use. To be administered mixed with a small amount of food, or directly into the mouth. Initial treatment is a single dose of 0.2 mg meloxicam/kg body weight on the first day. Treatment is to be continued once daily by oral administration (at 24-hour intervals) at a maintenance dose of 0.1 mg meloxicam/kg body weight. For longer term treatment, once a clinical response has been observed (after ≥ 4 days), the dose can be adjusted to the lowest effective individual dose reflecting that the degree of pain and inflammation associated with chronic musculo-skeletal disorders may vary over time. Particular care should be taken with regard to the accuracy of dosing. The suspension can be given using the measuring syringe provided in the package. The syringe fits onto the bottle and has a kg-body weight scale which corresponds to the maintenance dose (i.e. 0.1 mg meloxicam/kg body weight). Thus for the first day, twice the maintenance volume will be required. A clinical response is normally seen within 3–4 days. Treatment should be discontinued after 10 days at the latest if no clinical improvement is apparent.
One ml contains:
Active substance: Meloxicam 1.5 mg.
Excipient: Sodium benzoate 5 mg.
List of excipients
Sodium Benzoate
Saccharin Sodium
Sodium Carboxyl Methyl Cellulose
Colloidal Silicon Dioxide
Citric Acid Monohydrate
Sorbitol Solution
Disodium Hydrogen-Phosphate Dodecahydrate
Honey Flavour.
Contraindications
Do not use in pregnant or lactating animals.
Do not use in animals suffering from gastrointestinal disorders such as irritation and
haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic
disorders.
Do not use in known cases of hypersensitivity to the active substance or to any of the
excipients.
Do not use in dogs less than 6 weeks of age.
Special precautions for use
Special precautions for use in animals
Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a
potential risk of increased renal toxicity.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals.
People with known hypersensitivity to non-steroidal anti-inflammatory drugs
(NSAIDs) should avoid contact with the veterinary medicinal product.
Accidental ingestion of the product by a child may cause gastro-intestinal effects,
such as nausea and gastric pain.
Any uneaten medicated food must be disposed of immediately and the bowl washed
thoroughly.
Do not leave an unattended filled syringe in the sight or reach of children.
In case of accidental ingestion, seek medical advice immediately and show the
package leaflet or the label to the physician.
This product can cause eye irritation. In case of contact with the eyes, immediately
rinse thoroughly with water.
Adverse reactions (frequency and seriousness)
Typical adverse reactions of NSAIDs such as loss of appetite, vomiting, diarrhoea,
faecal occult blood, lethargy and renal failure have very rarely been reported. In very
rare cases haemorrhagic diarrhoea, haematemesis, gastrointestinal ulceration and
elevated liver enzymes have been reported. These side effects occur generally within
the first treatment week and are in most cases transient and disappear following
termination of the treatment but in very rare cases may be serious or fatal.
Use during pregnancy, lactation or lay
The safety of the veterinary medicinal product has not been established during
pregnancy and lactation
Interaction with other medicinal products and other forms of interaction
Other NSAIDs, diuretics, anticoagulants, aminoglycoside antibiotics and substances
with high protein binding may compete for binding and thus lead to toxic effects.
Meloxicam must not be administered in conjunction with other NSAIDs or
glucocorticosteroids.